Relatively little information exists on the prognosis for elderly patients with chronic hepatitis C (CHC). Moreover, the majority of randomized, clinical trials of hepatitis C treatment exclude elderly patients. Findings from a 2009 clinical study address risk of hepatocellular carcinoma, life expectancy and the influence of antiviral therapy in elderly patients with CHC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Floreani, A. et al. Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? J. Am. Geriatr. Soc. 54, 549–550 (2006).
Ikeda, K., et al. Necessities of interferon therapy in elderly patients with chronic hepatitis C. Am. J. Med. 122, 479–486, (2009).
Armstrong, G. L. et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144, 705–714 (2006).
Yoshizawa, H., Tanaka, J. & Miyakawa, Y. National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology 49, 7–17 (2006).
Heathcote, J. Prevention of hepatitis C-virus related hepatocellular carcinoma. Gastroenterology 127 (Suppl. 1), S294–S302 (2004).
Hot topics in hepatitis C virus treatment: Recommendations from an AISF/SIMID/SIMAST Expert Opinion Meeting [online], (2009).
Thabut, D. et al. Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? Am. J. Gastroenterol. 101, 1260–1267 (2006).
Iwasaki, Y. et al. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C. Hepatology 43, 54–63 (2006).
Marcus, E.-L. & Tur-Kaspa, R. Viral hepatitis in older adults. J. Am. Geriatr. Soc. 45, 755–763 (1997).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Floreani, A. Should antiviral therapy be offered to elderly patients?. Nat Rev Gastroenterol Hepatol 6, 503–504 (2009). https://doi.org/10.1038/nrgastro.2009.138
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2009.138
This article is cited by
-
Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis
Current Infectious Disease Reports (2016)
-
Viral Hepatitis in the Elderly
American Journal of Gastroenterology (2012)
-
Predictive Factors for Response to Peginterferon-Alpha and Ribavirin Treatment of Chronic HCV Infection in Patients Aged 65 Years and More
Digestive Diseases and Sciences (2010)